AlzChem Group AG
Vertically integrated specialty chemicals company focused on NCN chemistry.
ACT | F
Overview
Corporate Details
- ISIN(s):
- DE000A2YNT30
- LEI:
- 8945004EL7WZK3ERG181
- Country:
- Germany
- Address:
- Dr.-Albert-Frank-Str. 32, 83308 Trostberg
- Website:
- https://www.alzchem.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-01 07:00 |
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million continuing on …
|
English | 11.1 KB | ||
| 2024-02-21 10:49 | English | 3.9 KB | |||
| 2024-02-21 00:00 |
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023
|
German | 5.7 KB | ||
| 2024-01-11 15:28 |
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creati…
|
English | 12.6 KB | ||
| 2023-12-13 14:09 |
Alzchem Group AG awarded for sustainable supply chains: Outstanding result cert…
|
English | 8.1 KB | ||
| 2023-12-08 11:12 |
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas L…
|
English | 8.6 KB | ||
| 2023-11-13 00:00 |
Q3 statement / Q3 financial report 2023
|
English | 572.9 KB | ||
| 2023-10-26 06:55 |
Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in…
|
English | 10.6 KB | ||
| 2023-10-18 16:23 |
Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fi…
|
English | 8.6 KB | ||
| 2023-09-14 11:08 |
Alzchem Group AG: Creatine product 'Creavitalis': Wholesome taste and positive …
|
English | 13.2 KB | ||
| 2023-08-17 00:00 |
Half-yearly financial report 2023
|
English | 2.7 MB | ||
| 2023-08-03 07:00 |
Alzchem Group AG reports positive business development in the first half of 2023
|
English | 11.2 KB | ||
| 2023-07-27 15:42 | English | 3.9 KB | |||
| 2023-07-10 00:00 |
Ergänzung der Veröffentlichung vom 31.03.2023
|
German | 1.8 KB | ||
| 2023-05-15 00:00 |
Q1 statement / Q1 financial report 2023
|
English | 1.7 MB |
Automate Your Workflow. Get a real-time feed of all AlzChem Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AlzChem Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AlzChem Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-15 | Weichselbaumer, Dr. Georg | Board | Buy | None | 152,760.00 EUR |
| 2024-11-14 | Niedermaier, Herr Andreas | Board | Buy | None | 101,840.00 EUR |
| 2024-11-14 | Lösler, Andreas | Board | Buy | None | 81,472.00 EUR |
| 2024-11-14 | Englmaier, Klaus Dieter | Board | Buy | None | 76,380.00 EUR |
| 2024-11-12 | Englmaier, Klaus Dieter | Board | Buy | None | 45,209.40 EUR |
| 2024-11-12 | Englmaier, Klaus Dieter | Board | Buy | None | 35,227.00 EUR |
Peer Companies
